Tyra Biosciences, Inc. TYRA
19.57 USD -0.17 (-0.86%)
Regular-session close
19.57 0.00 0.00%
After hours · Nov 17, 4:33 PM ET
19.34 Day range 20.79
14.84 52-week range 40.65
- YTD
- -25.56%
- 1 year
- +23.08%
News
benzinga.com Nvidia To $200? Here Are 10 Top Analyst Forecasts For Wednesday Analysts cut targets for AMBQ, TYRA, NVDA, HUBB and CAN; raised CARL and RIOT targets, while downgrading NVDA and RIOT.benzinga.com Wedbush Maintains Outperform on Tyra Biosciences, Raises Price Target to $57 Wedbush analyst Robert Driscoll maintains Tyra Biosciences (NASDAQ:TYRA) with a Outperform and raises the price target from $53 to $57.
benzinga.com HC Wainwright & Co. Maintains Buy on Tyra Biosciences, Lowers Price Target to $27 HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Tyra Biosciences (NASDAQ:TYRA) with a Buy and lowers the price target from $29 to $27.
benzinga.com Tyra Biosciences Q3 EPS $(0.74) Misses $(0.69) Estimate Tyra Biosciences (NASDAQ:TYRA) reported quarterly losses of $(0.74) per share which missed the analyst consensus estimate of $(0.69) by 7.25 percent. This is a 48 percent decrease over losses of…
prnewswire.com Tyra Biosciences Reports Third Quarter 2026 Financial Results and Recent Highlights Reported initial Phase 2 SURF302 results for oral dabogratinib in FGFR3-altered low-grade IR NMIBC patients Completed $400 million financing, providing additional capital to advance dabogratinib's…
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session Gainers Biohaven (NYSE:BHVN) shares increased by 39.3% to $16.37 during Thursday's pre-market session. The company's market cap stands at $1.7 billion. Vogenx (NASDAQ:VOGX) stock rose 22.05% to…
